Advisory Research’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Advisory Research's GILD Position: Q4 2023 in Review
Advisory Research sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 3,809 shares — an estimated $285K sold.
Advisory Research first reported a position in GILD in Q1 2014 and held it in 16 quarters. The position peaked at $32.1M in Q2 2015. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.
- Advisory Research reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
- Advisory Research sold 3,809 Gilead Sciences shares in Q4 2023, an estimated $285K.
- Advisory Research first reported a position in Gilead Sciences in Q1 2014 and held it in 16 quarters.
- Advisory Research's Gilead Sciences position peaked at $32.1M in Q2 2015.
- 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.
Based on Advisory Research's 13F filing for Q4 2023, filed 13 Feb 2024.